Thematic Series on Clinical Cases on Haemostatic Disorders
Pierpaolo Di Micco Department of Medicine and Emergency Room, Fatebenefratelli Hospital of Naples, ItalyCorrespondence: Pierpaolo Di Micco Email pdimicco@libero.itIn daily clinical practice, venous thromboembolism (VTE) may be divided into provoked VTE or unprovoked VTE as a VTE event that...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-01-01
|
Series: | Journal of Blood Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/thematic-series-on-clinical-cases-on-haemostatic-disorders-peer-reviewed-article-JBM |
id |
doaj-707304d202df4b1a98af83accc4a632d |
---|---|
record_format |
Article |
spelling |
doaj-707304d202df4b1a98af83accc4a632d2020-11-25T00:11:29ZengDove Medical PressJournal of Blood Medicine1179-27362020-01-01Volume 11333451484Thematic Series on Clinical Cases on Haemostatic DisordersDi Micco PPierpaolo Di Micco Department of Medicine and Emergency Room, Fatebenefratelli Hospital of Naples, ItalyCorrespondence: Pierpaolo Di Micco Email pdimicco@libero.itIn daily clinical practice, venous thromboembolism (VTE) may be divided into provoked VTE or unprovoked VTE as a VTE event that appears without recent contact with common thrombotic risk factors.1 This classification is relevant, because the duration of anticoagulant treatment differs in cases of provoked or unprovoked VTE. In this way, provoked VTE is a VTE event that appears in the presence of such thrombotic risk factors. Common thrombotic risk factors have been identified by international guidelines as clinical conditions that need pharmacological prophylaxis to prevent VTE (i.e., recent surgery, recent hypomobilization, pregnancy, hormonal treatment, molecular inherited/acquired thrombophilia, cancer and its therapy).2 However, using this method, nearly 40% of VTE events may be considered unprovoked or idiopathic,1 although other clinical conditions such as inflammatory bowel diseases, immunopathological diseases and other molecular defects may be associated with VTE, as hypofibrinolysis and so on.3 Acquired resistance to protein C activity, postinflammatory increase of factor VIII, and antiphoshpholipid antibodies are all conditions that may be associated with VTE. https://www.dovepress.com/thematic-series-on-clinical-cases-on-haemostatic-disorders-peer-reviewed-article-JBMna |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Di Micco P |
spellingShingle |
Di Micco P Thematic Series on Clinical Cases on Haemostatic Disorders Journal of Blood Medicine na |
author_facet |
Di Micco P |
author_sort |
Di Micco P |
title |
Thematic Series on Clinical Cases on Haemostatic Disorders |
title_short |
Thematic Series on Clinical Cases on Haemostatic Disorders |
title_full |
Thematic Series on Clinical Cases on Haemostatic Disorders |
title_fullStr |
Thematic Series on Clinical Cases on Haemostatic Disorders |
title_full_unstemmed |
Thematic Series on Clinical Cases on Haemostatic Disorders |
title_sort |
thematic series on clinical cases on haemostatic disorders |
publisher |
Dove Medical Press |
series |
Journal of Blood Medicine |
issn |
1179-2736 |
publishDate |
2020-01-01 |
description |
Pierpaolo Di Micco Department of Medicine and Emergency Room, Fatebenefratelli Hospital of Naples, ItalyCorrespondence: Pierpaolo Di Micco Email pdimicco@libero.itIn daily clinical practice, venous thromboembolism (VTE) may be divided into provoked VTE or unprovoked VTE as a VTE event that appears without recent contact with common thrombotic risk factors.1 This classification is relevant, because the duration of anticoagulant treatment differs in cases of provoked or unprovoked VTE. In this way, provoked VTE is a VTE event that appears in the presence of such thrombotic risk factors. Common thrombotic risk factors have been identified by international guidelines as clinical conditions that need pharmacological prophylaxis to prevent VTE (i.e., recent surgery, recent hypomobilization, pregnancy, hormonal treatment, molecular inherited/acquired thrombophilia, cancer and its therapy).2 However, using this method, nearly 40% of VTE events may be considered unprovoked or idiopathic,1 although other clinical conditions such as inflammatory bowel diseases, immunopathological diseases and other molecular defects may be associated with VTE, as hypofibrinolysis and so on.3 Acquired resistance to protein C activity, postinflammatory increase of factor VIII, and antiphoshpholipid antibodies are all conditions that may be associated with VTE.
|
topic |
na |
url |
https://www.dovepress.com/thematic-series-on-clinical-cases-on-haemostatic-disorders-peer-reviewed-article-JBM |
work_keys_str_mv |
AT dimiccop thematicseriesonclinicalcasesonhaemostaticdisorders |
_version_ |
1725403757219414016 |